NCT00410358View on ClinicalTrials.gov

A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor.

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

February 29, 2008

Conditions
Advanced Solid Tumors
Interventions
DRUG

Gimatecan

Trial Locations (1)

Unknown

Novartis Investigative Site, Chiba Prefecture

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY